All Stories

  1. The Role of Fetal Autopsy in 2025: A Cornerstone in Fetal Loss Management and Genomic Medicine
  2. Integrating Molecular Diagnostics into Cervical Cancer Screening: A Workflow Using FFPE Tissue Samples
  3. Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review
  4. Primary Lung Tumors in Children: Insights from a Single-Center Case Series
  5. Evaluating HPV Viral Load and Multiple Infections for Enhanced Cervical Cancer Risk-Based Assessment
  6. AntiCD44 antibody-conjugated gold nanoparticles for targeted photothermal therapy of endometriotic cells
  7. Multiple Tumors in a Patient with Interleukin-2-Inducible T-Cell Kinase Deficiency: A Case Report
  8. Shiga toxin-producing Escherichia coli infection as a precipitating factor for atypical hemolytic-uremic syndrome
  9. Nerve Sheath Myxoma in Pregnancy: A Case Report
  10. Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
  11. Frozen Section of Placental Membranes and Umbilical Cord: A Valid Diagnostic Tool for Early-Onset Neonatal Sepsis Management
  12. Advancements in Gynecologic Pathology: A Molecular, Digital, and Biobanking Perspective
  13. From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models
  14. Hemostatic Profile of Intrauterine Growth-Restricted Neonates: Assessment with the Use of NATEM Assay in Cord Blood Samples
  15. The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis
  16. Outpatient surgery at the Pediatric Dermatology Unit
  17. The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
  18. Bovine Papillomavirus Type 1 Infection in an Equine Congenital Papilloma
  19. The Advantages of NGS Molecular Classification in Endometrial Cancer Diagnosis
  20. Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results
  21. Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
  22. POS0933 NAILFOLD VIDEOCAPILLAROSCOPY AS A POSSIBLE BIOMARKER TO DETECT ABERRANT PLACENTAL MICROCIRCULATION IN PREGNANT WOMEN: A PILOT STUDY
  23. Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
  24. Screening of Precancerous Lesions in Women with Human Papillomavirus (HPV) Infection by Molecular Typing and MicroRNA Analysis
  25. The nano-revolution in the diagnosis and treatment of endometriosis
  26. Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
  27. L1CAM variants cause two distinct imaging phenotypes on fetal MRI
  28. 33rd European Congress of Pathology – Abstracts
  29. A prospective study comparing rectal water contrast‐transvaginal ultrasonography with sonovaginography for the diagnosis of deep posterior endometriosis
  30. HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL PROGNOSTIC FACTORS IN HIGH-GRADE NON-ENDOMETRIOID CARCINOMAS OF THE ENDOMETRIUM (HG-NECs). IS IT POSSIBLE TO IDENTIFY SUB-GROUPS AT INCREASED RISK?
  31. New Insights into Endometrial Cancer
  32. Neoadjuvant imatinib as treatment preceding surgery for vulvar dermatofibrosarcoma protuberans
  33. SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice
  34. Evidence, evolution and pattern of contractile elements in villous vascular walls and stroma of human placentas of premature infants of different gestational ages. An immuno-morphologic comparative study
  35. Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial
  36. Multivariate Analysis Of Histopathological And Immunohistochemical Prognostic Factors In Endometrial Carcinoma. A Retrospective Pilot Study Of An Italian Regional Referral Center
  37. Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression
  38. Nasal Septum Warthin's Tumor: A Unique Case Report and Review of the Literature
  39. MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma
  40. Female Malignancies and Immunotherapy: What’s New?
  41. Concurrent benign tertiary syphilis and asymptomatic neurosyphilis in an immunocompetent patient
  42. Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations
  43. BOWEL OCCULT MICROSCOPIC ENDOMETRIOSIS IN RESECTION MARGINS IN DEEP COLORECTAL ENDOMETRIOSIS SPECIMENS HAS NO IMPACT ON THE LONG-TERM RISK OF RECURRENCE
  44. 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study
  45. PERSISTENCE OF RECTAL ENDOMETRIOSIS FOLLOWING LAPAROSCOPIC SHAVING OF RECTOVAGINAL NODULES INFILTRATING THE RECTUM
  46. Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects
  47. Fasting-mimicking diet and hormone therapy induce breast cancer regression
  48. P53 staining index and zonal staining patterns in actinic keratoses
  49. Steroids receptors immunohistochemical expression in different sites of endometriosis
  50. Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19
  51. Magnetic Resonance Rectal Enema Versus Computed Tomographic Colonography in the Diagnosis of Rectosigmoid Endometriosis
  52. A Prospective Study Comparing Three-Dimensional Rectal Water Contrast Transvaginal Ultrasonography and Computed Tomographic Colonography in the Diagnosis of Rectosigmoid Endometriosis
  53. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy
  54. Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3
  55. Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs
  56. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant
  57. Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms
  58. Circulating placental growth factor (PLGF) concentration in pregnant women with endometriosis: a case-control study
  59. Dienogest for pain and intestinal symptoms caused by rectosigmoid endometriosis: prospective cohort study
  60. Magnetic resonance with gel enema (MR-e) versus computed tomographic colonography (CTC) for diagnosing rectosigmoid endometriosis
  61. Preoperative treatment with leuprolide acetate and ulipristal acetate before outpatient hysteroscopic myomectomy: prospective comparative study
  62. Total disc replacement for lumbar degenerative disc disease: single centre 20 years experience
  63. What can we learn from the histopathology of retained placenta? A 15-year experience at a regional referral center
  64. Pathophysiology of pain in patients with peritoneal endometriosis
  65. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas
  66. Transvaginal sonography with vs without bowel preparation in diagnosis of rectosigmoid endometriosis: prospective study
  67. Giant Hepatic Hemangioma and Placental Chorangiosis: A Unique Case of Stillbirth?
  68. Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
  69. Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance?
  70. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis
  71. Does Bowel Preparation Improve the Performance of Rectal Water Contrast Transvaginal Ultrasonography in Diagnosing Rectosigmoid Endometriosis?
  72. Ureteral endometriosis: a systematic review of epidemiology, pathogenesis, diagnosis, treatment, risk of malignant transformation and fertility
  73. A Survey on the Knowledge and Attitudes of Italian Medical Students toward Body Donation: Ethical and Scientific Considerations
  74. Peritoneal carcinomatosis from ovarian paraganglioma: Report of a rare case and systematic review of the literature
  75. Inflammatory Response Modulation through a PPARγ Agonist during Surgically Induced Visceral Ischemia in an Animal Model
  76. Changes in Androgen Receptor Expression as a Molecular Marker of Progression from Normal Epithelium to Invasive Cancer in Elderly Patients with Penile Squamous Cell Carcinoma
  77. Kidney Ultrastructure by Atomic Force Microscopy Imaging Directly From Formalin Fixed-Paraffin Embedded Biopsy: Is This a Dream Come True?
  78. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids
  79. PERITONEAL CARCINOMATOSIS FROM PRIMARY MALIGNANT OVARIAN PARAGANGLIOMA: A CHALLENGING MANAGEMENT OF AN EXTREMELY RARE CASE
  80. Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
  81. Zinner Syndrome: A Diagnostic Challenge. The Aid of Morphology, Embryology, and Immunohistochemistry
  82. Cutaneous metastasis from vulvar squamous cell carcinoma: a rare occurrence that should not be forgotten
  83. Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis
  84. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair
  85. Virtopsy in conjoined ischiopagus twins
  86. Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model
  87. Computed tomographic colonographyvsrectal water- contrast transvaginal sonography in diagnosis of rectosigmoid endometriosis: a pilot study
  88. Magnetic resonance enemavsrectal water-contrast transvaginal sonography in diagnosis of rectosigmoid endometriosis
  89. Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis
  90. Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report
  91. Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer
  92. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study
  93. A case of thyroid cancer on the track of the radiofrequency electrode 30 months after percutaneous ablation
  94. Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study.
  95. Incidental Diagnosis of Giant Cell Tumor After Urachal Remnant Removal in a Thalassemic Child
  96. Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus
  97. Excision of Ectopic Adrenocortical Tissue During Laparoscopy for Pelvic Endometriosis
  98. Computed Tomographic Colonography in the Diagnosis of Recto-Sigmoid Endometriosis: A Pilot Study
  99. Real-Time Transvaginal Elastography of Recto-Sigmoid Endometriotic Nodules: Correlation With Symptoms and Histology
  100. Advances in pharmacotherapy for treating endometriosis
  101. OP03.01: Elastographic features of ovarian dermoid cysts
  102. Spontaneous Uroperitoneum and Preterm Delivery in a Patient With Bladder Endometriosis
  103. Atypical Cellular Chorangioma
  104. Intestinal Endometriosis: Mimicker of Inflammatory Bowel Disease?
  105. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery
  106. Human Papillomavirus (HPV) Infection in Squamous Cell Carcinomas Arising From the Oropharynx: Detection of HPV DNA and p16 Immunohistochemistry as Diagnostic and Prognostic Indicators—A Pilot Study
  107. Post-partum hemorrhage and malpractice claims: What can we learn from the findings of placental examination and endometrial curettage? A retrospective analysis of surgical pathology reports
  108. Secondary malignancies of the uterine cervix: a potential diagnostic pitfall
  109. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
  110. Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival
  111. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
  112. BRAF(V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma
  113. Clinicopathologic and Immunohistochemical Features of Ovarian Clear Cell Carcinomas in Comparison With Type I and Type II Tumors
  114. O753 SECONDARY MALIGNANCY TO THE UTERINE CERVIX: TOO UNCOMMON TO BE CONSIDERED? THE ROLE OF THE PATHOLOGIST
  115. Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study
  116. Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models
  117. Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
  118. Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women
  119. Morphological and immunocytochemical diagnosis of thyroiditis: Comparison between conventional and liquid-based cytology
  120. Free Papers
  121. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size
  122. Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations
  123. Borderline Mucinous Endocervical Tumor as a Link Between the Endometriotic Cyst and Ovarian Primary Squamous Cell Carcinoma
  124. Ovarian cancer arising in endometrioid cysts: ultrasound findings
  125. Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma
  126. Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical study
  127. The Decrease of Serum Levels of Human Neutrophil Alpha-Defensins Parallels with the Surgery-Induced Amelioration of NASH in Obesity
  128. Morphology and Immunophenotyping of a Monolateral Ovotestis in a 46,XderY/45,X Mosaic Individual With Ambiguous Genitalia
  129. Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the Cervix
  130. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease
  131. Colonic Carcinoma Metastatic to the Endometrium
  132. RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus
  133. Plantar Melanoma That Mimics Melanocytic Nevi: A Report of 4 Cases With Lymph Node Metastases and With Review of Positive and Negative Controls
  134. Accuracy of Papanicolaou Smears in Cervical Cancer Patients Treated With Radiochemotherapy Followed by Radical Surgery
  135. Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease
  136. Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas
  137. NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
  138. PA.92 A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
  139. Morphological Effects of Radiochemotherapy on Cervical Carcinoma
  140. Should a renal biopsy be performed at the first relapse of ‘clinical nephrotic syndrome’?
  141. Ovarian endomyometrioma with atypias: description of a case
  142. Endometrial carcinoma recurring as carcinosarcoma: Report of two cases
  143. Glassy cell carcinoma of the endometrium: A case report and review of the literature
  144. Ovarian serous carcinoma presenting with mediastinal lymphadenopathy 20 months before the intraabdominal mass: Role of immunohistochemistry
  145. Solitary choroid plexus tuberculoma in an adult patient
  146. Celecoxib Up-Regulates the Expression of the   Chain of T Cell Receptor Complex in Tumor-Infiltrating Lymphocytes in Human Cervical Cancer
  147. Hepatocyte growth factor and transforming growth factor β1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis
  148. Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis